Biotech

Page 5 of 18

Cassava Sciences—a drugmaker with no products on the market—is currently 2021’s best biotech performer
Health

Cassava Sciences—a drugmaker with no products on the market—is currently 2021’s best biotech performer

By Cristin Flanagan and Bloomberg
June 9, 2021
Celmatix founder and CEO Piraye Beim wants to delay menopause by 15 years.
MPW

This biotech startup thinks it can delay menopause by 15 years. That would transform women’s lives

By
April 19, 2021
Meet the most innovative and inventive pharmaceutical companies of 2021
Health

Meet the most innovative and inventive pharmaceutical companies of 2021

By Sy Mukherjee and IDEA Pharma
April 16, 2021
What Genentech is doing to fix biotech’s diversity problem
Leadership

What Genentech is doing to fix biotech’s diversity problem

By
April 7, 2021
Photo of CytoSeek CEO Carolyn Porter
Tech

New venture fund backs CytoSeek, a startup looking to give “superpowers” to cancer-fighting T-cells

By
March 16, 2021
A man with his shirt off and wearing a mask receives a COVID-19 vaccination from a health worker wearing PPE.
Health

As mutant COVID variants multiply, the hunt is on for a ‘universal’ kill-all vaccine

By
February 19, 2021
Know when to fold ’em: How a company best known for playing games used A.I. to solve one of biology’s greatest mysteries
Tech

Know when to fold ’em: How a company best known for playing games used A.I. to solve one of biology’s greatest mysteries

By
November 30, 2020
Photo of Air Street Capital Founder Nathan Benaich.
Tech

Twitter and a Supercell billionaire are backing a new A.I.-focused venture capital fund

By
October 30, 2020
OneUnited Bank CEO Kevin Cohee
Finance

Biogen moves $10 million to Black-owned OneUnited, joining the Fortune 500 trend to ‘Bank Black’

By
September 3, 2020
Shares of obscure biotech firm Novavax soar 32% on coronavirus vaccine funding
Finance

Shares of obscure biotech firm Novavax soar 32% on coronavirus vaccine funding

By
July 7, 2020
Moderna coronavirus vaccine trial
Health

Moderna releases promising—but early—new coronavirus vaccine data

By
May 18, 2020
Will COVID-19 change how Big Pharma does clinical trials?
Magazine

Will COVID-19 change how Big Pharma does clinical trials?

By
May 15, 2020
Gilead-Sciences-Remdesivir
Health

Remdesivir is the first coronavirus treatment. So why is Gilead’s stock plunging?

By
May 1, 2020
George Scangos coronavirus czar biotech
Newsletters

Pharma vet and former Biogen chief to lead biotech industry’s coronavirus response

By
March 2, 2020
What Andreessen’s ‘Bio Fund III’ means for healthcare
Newsletters

What Andreessen’s ‘Bio Fund III’ means for healthcare

By
February 5, 2020

Most Popular